Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022.
Journal
Journal of the National Cancer Institute. Monographs
ISSN: 1745-6614
Titre abrégé: J Natl Cancer Inst Monogr
Pays: United States
ID NLM: 9011255
Informations de publication
Date de publication:
04 05 2023
04 05 2023
Historique:
received:
03
11
2022
revised:
25
01
2023
accepted:
31
01
2023
pmc-release:
04
05
2024
medline:
5
5
2023
pubmed:
4
5
2023
entrez:
4
5
2023
Statut:
ppublish
Résumé
The overall goal of the annual Transdisciplinary Research in Energetics and Cancer (TREC) Training Workshop is to provide transdisciplinary training for scientists in energetics and cancer and clinical care. The 2022 Workshop included 27 early-to-mid career investigators (trainees) pursuing diverse TREC research areas in basic, clinical, and population sciences. The 2022 trainees participated in a gallery walk, an interactive qualitative program evaluation method, to summarize key takeaways related to program objectives. Writing groups were formed and collaborated on this summary of the 5 key takeaways from the TREC Workshop. The 2022 TREC Workshop provided a targeted and unique networking opportunity that facilitated meaningful collaborative work addressing research and clinical needs in energetics and cancer. This report summarizes the 2022 TREC Workshop's key takeaways and future directions for innovative transdisciplinary energetics and cancer research.
Identifiants
pubmed: 37139978
pii: 7150920
doi: 10.1093/jncimonographs/lgad005
pmc: PMC10157760
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
149-157Subventions
Organisme : NCI NIH HHS
ID : R25 CA203650
Pays : United States
Organisme : NIMHD NIH HHS
ID : K01MD014761
Pays : United States
Organisme : NCI NIH HHS
ID : K22 CA262340
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Organisme : NIMHD NIH HHS
ID : K01 MD014761
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA247263
Pays : United States
Organisme : NCI NIH HHS
ID : R25CA203650
Pays : United States
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
J Thorac Oncol. 2021 Aug;16(8):1333-1348
pubmed: 34144926
Health Educ Behav. 2015 Apr;42(1 Suppl):123S-132S
pubmed: 25829111
Cancers (Basel). 2022 Jun 14;14(12):
pubmed: 35740596
Adv Physiol Educ. 2015 Dec;39(4):411-3
pubmed: 26628668
Physiol Rep. 2022 Apr;10(8):e15192
pubmed: 35439354
Int J Mol Sci. 2021 Feb 01;22(3):
pubmed: 33535537
Cancer. 2019 Dec 1;125(23):4124-4133
pubmed: 31420878
Proc Biol Sci. 2021 Sep 8;288(1958):20210219
pubmed: 34493075
Med Educ. 2021 Apr;55(4):430-440
pubmed: 32955728
Cancer Causes Control. 2013 Apr;24(4):695-704
pubmed: 23378138
Transl Oncol. 2021 Oct;14(10):101178
pubmed: 34293684
Sci Rep. 2022 Mar 24;12(1):5074
pubmed: 35332225
J Cancer Surviv. 2023 Feb;17(1):120-129
pubmed: 33675013
BMJ Open. 2019 Sep 20;9(9):e030080
pubmed: 31542747
Nat Rev Cancer. 2017 Sep 25;17(10):620-632
pubmed: 28943640
Cell Rep. 2018 Oct 2;25(1):47-56.e3
pubmed: 30282037
Transl Behav Med. 2021 Mar 16;11(2):549-562
pubmed: 32065834
Reproduction. 2017 Apr;153(4):R133-R149
pubmed: 28115579
J Natl Cancer Inst. 2015 Nov 07;108(1):
pubmed: 26547926
Cancer Metastasis Rev. 2010 Dec;29(4):641-53
pubmed: 20821253
Endocrinology. 2009 Jun;150(6):2537-42
pubmed: 19372199
Acad Med. 2013 Apr;88(4):488-96
pubmed: 23425990
Cancers (Basel). 2018 Jun 01;10(6):
pubmed: 29865211
Microbiome. 2021 May 5;9(1):100
pubmed: 33952353
BMC Proc. 2017 Dec 04;11(Suppl 12):22
pubmed: 29375663
Lab Chip. 2020 Jun 7;20(11):2009-2019
pubmed: 32379852
Cancer Res. 2019 May 15;79(10):2447-2456
pubmed: 31068341
J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):4
pubmed: 25575142
CA Cancer J Clin. 2021 Mar;71(2):107-139
pubmed: 33326126
EMBO Rep. 2018 Dec;19(12):
pubmed: 30396884
Mol Cancer Res. 2020 Jan;18(1):130-139
pubmed: 31628201
Nat Med. 2019 Jan;25(1):141-151
pubmed: 30420753
Clin Cancer Res. 2016 Apr 1;22(7):1565-71
pubmed: 26792261
Nat Commun. 2022 Mar 3;13(1):1157
pubmed: 35241678
Health Res Policy Syst. 2018 Jul 11;16(1):60
pubmed: 29996848
J Gen Intern Med. 2012 Aug;27(8):985-91
pubmed: 22528615
Integr Cancer Ther. 2021 Jan-Dec;20:1534735420986615
pubmed: 33870744